Hui Jin
Impact in
- Health top 0.5%
- Vaccine Coverage and Hesitancy
- Infectious Diseases top 1%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Viral gastroenteritis research and epidemiology
Papers in
- Epidemiology 39
- Influenza Virus Research Studies 13
- Hepatitis B Virus Studies 9
-
- SARS-CoV-2 and COVID-19 Research 19
- Viral gastroenteritis research and epidemiology 10
- COVID-19 Clinical Research Studies 8
- Co-authors
- Qiang Wang (33 shared papers)Tauseef Ahmad (24 shared papers)Liuqing Yang (25 shared papers)Leesa Lin (10 shared papers)Mukhtiar Baig (9 shared papers)Naiyang Shi (30 shared papers)Mengyun Zheng (9 shared papers)Chunxiao Duan (7 shared papers)
- Journals
- Human Vaccines & Immunotherapeutics (18 papers)Epidemiology and Infection (7 papers)PLoS ONE (6 papers)Vaccine (6 papers)Vaccines (5 papers)
- Partner nations
- ChinaBangladeshUnited States
In The Last Decade
Hui Jin
219 papers receiving 3.8k citations
Hui Jin's Hit Papers
Peers
Comparison fields: 5 of 182
- Health 639
- Infectious Diseases 856
- Modeling and Simulation 212
- Hepatology 187
- Epidemiology 621
Countries citing papers authored by Hui Jin
This map shows the geographic impact of Hui Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Jin more than expected).
Fields of papers citing papers by Hui Jin
This network shows the impact of papers produced by Hui Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Jin. The network helps show where Hui Jin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui Jin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 240 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial Hit paper breakdown → | 2021 | 370 |
| 2 | Vaccination against COVID-19: A systematic review and meta-analysis of acceptability and its predictors Hit paper breakdown → | 2021 | 221 |
| 3 | 2018 | 163 | |
| 4 | 2018 | 156 | |
| 5 | 2020 | 120 | |
| 6 | 2013 | 88 | |
| 7 | 2021 | 87 | |
| 8 | 2006 | 86 | |
| 9 | 2008 | 83 | |
| 10 | 2018 | 79 | |
| 11 | 2019 | 75 | |
| 12 | 2021 | 66 | |
| 13 | 2018 | 66 | |
| 14 | 2019 | 64 | |
| 15 | 2004 | 59 | |
| 16 | 2004 | 54 | |
| 17 | 2022 | 46 | |
| 18 | 2014 | 45 | |
| 19 | 2023 | 44 | |
| 20 | 2023 | 41 |
About Hui Jin
Hui Jin is a scholar working on Epidemiology, Infectious Diseases, Health, Hepatology and Molecular Biology, having authored 240 papers that have together received 3.9k indexed citations. Recurring topics across this work include Vaccine Coverage and Hesitancy (24 papers), SARS-CoV-2 and COVID-19 Research (19 papers), Hepatitis Viruses Studies and Epidemiology (15 papers), Influenza Virus Research Studies (13 papers), COVID-19 epidemiological studies (11 papers), Viral gastroenteritis research and epidemiology (10 papers), Hepatitis B Virus Studies (9 papers) and COVID-19 Clinical Research Studies (8 papers). The work is most often cited by research in Health (639 citations), Infectious Diseases (856 citations), Modeling and Simulation (212 citations), Hepatology (187 citations) and Epidemiology (621 citations). Hui Jin has collaborated with scholars based in China, Bangladesh and United States. Frequent co-authors include Qiang Wang, Tauseef Ahmad, Liuqing Yang, Leesa Lin, Mukhtiar Baig, Naiyang Shi, Mengyun Zheng, Chunxiao Duan, Donglei Wang and Hui Li. Their work appears in journals such as Human Vaccines & Immunotherapeutics, Epidemiology and Infection, PLoS ONE, Vaccine and Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.